Cargando…

Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) are anti-hyperglycemic agents that prevent glucose reabsorption in proximal tubular cells. SGLT2i improves renal outcomes in both diabetic and non-diabetic patients, indicating it may have beneficial effects beyond glycemic control. Here, we demonst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Mengyuan, Molina, Judith, Kim, Jin-Ju, Mallela, Shamroop K, Ahmad, Anis, Varona Santos, Javier, Al-Ali, Hassan, Mitrofanova, Alla, Sharma, Kumar, Fontanesi, Flavia, Merscher, Sandra, Fornoni, Alessia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2023
Materias:	Cell Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185338/ https://www.ncbi.nlm.nih.gov/pubmed/37129368 http://dx.doi.org/10.7554/eLife.83353

Ejemplares similares

Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome
por: Kim, Jin-Ju, et al.
Publicado: (2020)

ABCA1 deficiency contributes to podocyte pyroptosis priming via the APE1/IRF1 axis in diabetic kidney disease
por: Ito, Marie, et al.
Publicado: (2023)

The Vicious Cycle of Renal Lipotoxicity and Mitochondrial Dysfunction
por: Ge, Mengyuan, et al.
Publicado: (2020)

Sphingomyelin phosphodiesterase acid like 3B (SMPDL3b) regulates Perilipin5 (PLIN5) expression and mediates lipid droplet formation
por: Mallela, Shamroop Kumar, et al.
Publicado: (2022)

Implications of Sphingolipid Metabolites in Kidney Diseases
por: Mallela, Shamroop kumar, et al.
Publicado: (2022)

Podocyte Pathology and Nephropathy – Sphingolipids in Glomerular Diseases
por: Merscher, Sandra, et al.
Publicado: (2014)

The podocyte: glomerular sentinel at the crossroads of innate and adaptive immunity
por: Burke, George W., et al.
Publicado: (2023)

Role of Sphingolipid Signaling in Glomerular Diseases: Focus on DKD and FSGS
por: Mitrofanova, Alla, et al.
Publicado: (2020)

New insights into renal lipid dysmetabolism in diabetic kidney disease
por: Mitrofanova, Alla, et al.
Publicado: (2021)

Use of Lipid-Modifying Agents for the Treatment of Glomerular Diseases
por: Ge, Mengyuan, et al.
Publicado: (2021)

Mitochondrial Contribution to Inflammation in Diabetic Kidney Disease
por: Mitrofanova, Alla, et al.
Publicado: (2022)

Patient-derived podocyte spheroids reveal new insights into the etiopathogenesis of Alport syndrome
por: Romero-Guevara, Ricardo, et al.
Publicado: (2023)

Novel Therapies for Alport Syndrome
por: Chavez, Efren, et al.
Publicado: (2022)

Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease
por: Wright, Matthew B., et al.
Publicado: (2021)

Podocyte Depletion in Thin GBM and Alport Syndrome
por: Wickman, Larysa, et al.
Publicado: (2016)

Podocyte-Specific GLUT4-Deficient Mice Have Fewer and Larger Podocytes and Are Protected From Diabetic Nephropathy
por: Guzman, Johanna, et al.
Publicado: (2014)

Effects of High Glucose and Lipotoxicity on Diabetic Podocytes
por: Nakamichi, Ran, et al.
Publicado: (2021)

Nonimmunologic targets of immunosuppressive agents in podocytes
por: Yoo, Tae-Hyun, et al.
Publicado: (2015)

Modelling X-linked Alport Syndrome With Induced Pluripotent Stem Cell-Derived Podocytes
por: Lau, Ricky Wai Kiu, et al.
Publicado: (2021)

Fetuin‐A aggravates lipotoxicity in podocytes via interleukin‐1 signaling
por: Orellana, Jana M., et al.
Publicado: (2017)

Molecular and functional characterization of urine‐derived podocytes from patients with Alport syndrome
por: Iampietro, Corinne, et al.
Publicado: (2020)

Empagliflozin does not reverse lipotoxicity-induced impairment in human myeloid angiogenic cell bioenergetics
por: Cinquegrani, Gloria, et al.
Publicado: (2022)

Clinical trial recommendations for potential Alport syndrome therapies
por: Weinstock, B. André, et al.
Publicado: (2020)

Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis
por: Otalora, Lilian, et al.
Publicado: (2019)

Renal Lipotoxicity-Associated Inflammation and Insulin Resistance Affects Actin Cytoskeleton Organization in Podocytes
por: Martínez-García, Cristina, et al.
Publicado: (2015)

Preterm birth leads to a decreased number of differentiated podocytes and accelerated podocyte differentiation
por: Zhang, Lulu, et al.
Publicado: (2023)

The Accumulation of VEGFA in the Glomerular Basement Membrane and Its Relationship with Podocyte Injury and Proteinuria in Alport Syndrome
por: Wang, Haiyan, et al.
Publicado: (2015)

Cyclodextrin Protects Podocytes in Diabetic Kidney Disease
por: Merscher-Gomez, Sandra, et al.
Publicado: (2013)

Dynamin-mediated Nephrin Phosphorylation Regulates Glucose-stimulated Insulin Release in Pancreatic Beta Cells
por: Jeon, Jongmin, et al.
Publicado: (2012)

Glucose- and Non-Glucose-Induced Mitochondrial Dysfunction in Diabetic Kidney Disease
por: Ito, Marie, et al.
Publicado: (2022)

A Comparative Proteomic Analysis of Extracellular Vesicles Associated With Lipotoxicity
por: Nakao, Yasuhiko, et al.
Publicado: (2021)

Functions of Ceramide Synthase Paralogs YPR114w and YJR116w of Saccharomyces cerevisiae
por: Mallela, Shamroop K., et al.
Publicado: (2016)

Metabolism, Energetics, and Lipid Biology in the Podocyte – Cellular Cholesterol-Mediated Glomerular Injury
por: Merscher, Sandra, et al.
Publicado: (2014)

Alport Syndrome With Kidney Cysts Is Still Alport Syndrome
por: Savige, Judy, et al.
Publicado: (2021)

GPR43 activation-mediated lipotoxicity contributes to podocyte injury in diabetic nephropathy by modulating the ERK/EGR1 pathway
por: Lu, Jian, et al.
Publicado: (2022)

APOL1 renal risk variants promote cholesterol accumulation in tissues and cultured macrophages from APOL1 transgenic mice
por: Ryu, Jung-Hwa, et al.
Publicado: (2019)

DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome
por: Richter, Hans, et al.
Publicado: (2018)

Modular Microphysiological System for Modeling of Biologic Barrier Function
por: Ishahak, Matthew, et al.
Publicado: (2020)

Controversies in Podocyte Loss: Death or Detachment?
por: Yin, Lijun, et al.
Publicado: (2021)

Editorial: Molecular and Cellular Biology of podocytes
por: Lorenzo, Hans Kristian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ua99h2110pqeoi686vv62tgt76